NZ502270A - Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines - Google Patents

Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines

Info

Publication number
NZ502270A
NZ502270A NZ502270A NZ50227098A NZ502270A NZ 502270 A NZ502270 A NZ 502270A NZ 502270 A NZ502270 A NZ 502270A NZ 50227098 A NZ50227098 A NZ 50227098A NZ 502270 A NZ502270 A NZ 502270A
Authority
NZ
New Zealand
Prior art keywords
cytokines
derivatives
conjunction
secretory peptide
treating cancer
Prior art date
Application number
NZ502270A
Inventor
Paul O Sheppard
Laura J Jelinek
Stephen R Jaspers
Theodore E Whitmore
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of NZ502270A publication Critical patent/NZ502270A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Isolated polynucleotides encoding mammalian Secretory peptide-9 (Zsig9), and related compositions and methods including antibodies and antiidiotypic antibodies are disclosed. Over-expression of these polypeptides is indicative of the presence of cancer. Antibodies and antisense nucleotides can be used therapeutically to either treat the disease or diagnose the presence of tumours.
NZ502270A 1997-07-03 1998-07-02 Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines NZ502270A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US88808897A 1997-07-03 1997-07-03
US5170497P 1997-07-03 1997-07-03
US8598398P 1998-05-19 1998-05-19
US8133898A 1998-05-19 1998-05-19
US8989998P 1998-06-17 1998-06-17
US9900598A 1998-06-17 1998-06-17
PCT/US1998/013859 WO1999001554A1 (en) 1997-07-03 1998-07-02 Mammalian secretory peptide-9

Publications (1)

Publication Number Publication Date
NZ502270A true NZ502270A (en) 2000-10-27

Family

ID=27556638

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ502270A NZ502270A (en) 1997-07-03 1998-07-02 Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines

Country Status (6)

Country Link
EP (1) EP0998559A1 (en)
JP (1) JP2002503112A (en)
AU (1) AU741557B2 (en)
CA (1) CA2294702A1 (en)
NZ (1) NZ502270A (en)
WO (1) WO1999001554A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4005599A (en) * 1998-05-19 1999-12-06 Zymogenetics Inc. Method for diagnosis and treatment of cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2004044165A2 (en) * 2002-11-13 2004-05-27 Incyte Corporation Lipid-associated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003157A1 (en) * 1991-07-29 1993-02-18 Dana Farber Cancer Institute Plasmids for the rapid preparation of modified proteins

Also Published As

Publication number Publication date
JP2002503112A (en) 2002-01-29
EP0998559A1 (en) 2000-05-10
WO1999001554A1 (en) 1999-01-14
CA2294702A1 (en) 1999-01-14
AU8286698A (en) 1999-01-25
AU741557B2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
DK1007537T3 (en) Receptor protein designated 2F1
HK1022174A1 (en) Antigen binding fragments that specifically detectcancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
ES2154354T3 (en) LIGANDOS TIE-2, METHODS TO OBTAIN THEM AND ITS USES.
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
IL193886A0 (en) Antibodies that bind to ldcam sequences
EP1242060A4 (en) Treatment of metastatic disease
IL175698A0 (en) Phosphodiesterase 8a
MX9705349A (en) Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma.
TR200001646T2 (en) Mamaglobin, a secreted breast cancer protein.
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
WO1996022373A3 (en) Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
ZA897858B (en) Family of high affinity,modified antibodies for cancer treatment
DE69932153D1 (en) Phosphodiesterase 10
MX9801264A (en) Control of cd44 gene expression for therapeutic use.
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
MX9606559A (en) Cancer therapy using lymphotoxin.
NO330924B1 (en) Isolated antibody or antibody fragment, immunoconjugate, use of an immunoconjugate, a therapeutically effective amount of an immunoconjugate or antibody or antibody fragment for the preparation of preparations for selective cell destruction, treatment of a disease state, or diagnosis of metastasis or prostate cancer, as well as p.
NZ502270A (en) Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines
ES8704082A1 (en) Tumour therapeutic agent and process for its preparation.
CA2067797A1 (en) Production and use of human nm23 protein and antibodies therefor
ATE108188T1 (en) LAMININ BINDING PEPTIDE FRAGMENTS.
MX9805299A (en) Novel polynucleotides panc1a and panc1b associated with pancreatic cancer.

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)